Roger Dmochowski led the peer-review process as the Associate Editor responsible for the paper.
Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome
Article first published online: 12 MAR 2013
© 2013 Wiley Periodicals, Inc.
Neurourology and Urodynamics
Volume 33, Issue 3, pages 331–334, March 2014
How to Cite
Hsiao, S.-M., Lin, H.-H. and Kuo, H.-C. (2014), Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome. Neurourol. Urodyn., 33: 331–334. doi: 10.1002/nau.22394
Conflict on interest: none.
This post-marketing surveillance study was sponsored by Astellas Pharma Taiwan, Inc.
- Issue published online: 15 MAR 2014
- Article first published online: 12 MAR 2013
- Manuscript Accepted: 13 FEB 2013
- Manuscript Received: 11 NOV 2012
This article has been cited by:
- 1Risk Factors for the Failure of Antimuscarinic Treatment With Solifenacin in Women With Overactive Bladder, Urology, 2013, 82, 5, 1044, , , , , , , , ,